TIMI Risk Score (STEMI)

30-day mortality after ST-elevation MI treated with fibrinolysis
Age
History of diabetes, hypertension, or angina
Systolic BP < 100 mmHg
Heart rate > 100/min
Killip class II–IV
Weight < 67 kg
Anterior STEMI or new LBBB
Time to treatment > 4 hours

About this score

When to use

Estimates 30-day mortality at presentation with ST-elevation MI in patients eligible for fibrinolysis, from ten weighted bedside variables. ⁦[1]⁩

Pearls and pitfalls

• It was developed in the InTIME II fibrinolysis trial; the mortality estimates describe that study population. ⁦[1]⁩
• 30-day mortality rose more than 40-fold from a score of 0 to the highest scores. ⁦[1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation (InTIME II substudy). Ten weighted variables predicted 30-day mortality, which rose more than 40-fold from a score of 0 to > 8.
Circulation, 2000
Open source
Last reviewed: 2026-09
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore